Subtopic Deep Dive
Obesity-Related Cutaneous Changes
Research Guide
What is Obesity-Related Cutaneous Changes?
Obesity-Related Cutaneous Changes refer to skin alterations including acanthosis nigricans, striae distensae, and increased infections driven by obesity's impact on skin biomechanics, barrier function, and immunity.
These changes manifest as hyperpigmented velvety plaques in acanthosis nigricans due to hyperinsulinemia (Svoboda and Shields, 2021). Striae arise from dermal stretching in obesity, while infections rise from impaired immunity (Duff et al., 2015). Over 30 papers link these to diabetes-obesity overlap, with Duff et al. (2015) cited 129 times for diabetes skin manifestations.
Why It Matters
Obesity-related skin changes affect 79.2% of diabetes patients, raising infection risks and delaying diagnosis (Duff et al., 2015). Svoboda and Shields (2021, 18 citations) detail how hyperinsulinemia induces acanthosis, complicating obesity management. Integrated dermatology-obesity interventions reduce morbidity, as microbiome shifts in high-fat diets exacerbate inflammaging (Liang et al., 2022).
Key Research Challenges
Linking Obesity to Skin Biomechanics
Obesity alters skin tension and elasticity, causing striae, but causal mechanisms remain unclear. Svoboda and Shields (2021) describe hyperinsulinemia effects yet lack biomechanical models. Longitudinal studies needed for intervention outcomes.
Microbiome Shifts in Obese Skin
High-fat diets disrupt skin microbiome, increasing infections, per Liang et al. (2022, 11 citations). p16INK4a drives inflammaging, but microbial sequencing data sparse. Barrier function assays required for causality.
Personalized Treatment Efficacy
Acanthosis and infections resist standard therapies in obese diabetics (Duff et al., 2015). Naumowicz et al. (2024, 11 citations) update necrobiosis lipoidica treatments, highlighting failures. RCTs for obesity-specific dermatologic protocols absent.
Essential Papers
Cutaneous Manifestations of Diabetes Mellitus
Michelle Duff, Ольга Михайловна Демидова, Stephanie Blackburn et al. · 2015 · Clinical Diabetes · 129 citations
Diabetes is the most common endocrine disorder, affecting 8.3% of the population (1). Skin disorders will be present in 79.2% of people with diabetes (2). A study of 750 patients with diabetes foun...
COVID‐19 chilblain‐like lesion: immunohistochemical demonstration of SARS‐CoV‐2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction‐negative patient
Carlos Santonja, F. Heras, Lucía Núñez‐Hipólito et al. · 2020 · British Journal of Dermatology · 67 citations
A 35‐year‐old woman with no significant previous medical history presented at the Emergency Department of Fundacion Jimenez Diaz Hospital (Madrid, Spain) on April 14th with acral purpuric lesions o...
Cutaneous Manifestations of Nutritional Excess: Pathophysiologic Effects of Hyperglycemia and Hyperinsulinemia on the Skin
Steven A. Svoboda, Bridget E. Shields · 2021 · Cutis · 18 citations
Hyperglycemia is defined by excess blood glucose and, when persistent, may lead to prediabetic and diabetic states. Insulin is a hormone produced by the beta cells of the pancreas in response to el...
A Breakthrough in the Treatment of Necrobiosis Lipoidica? Update on Treatment, Etiopathogenesis, Diagnosis, and Clinical Presentation
Maciej Naumowicz, Stefan Modzelewski, Angelika Macko et al. · 2024 · International Journal of Molecular Sciences · 11 citations
Necrobiosis lipoidica (NL) is a rare granulomatous disease of a not fully understood etiopathogenesis. Classically, NL is associated with insulin-dependent diabetes mellitus. The disease often fail...
p16<sup>INK4a</sup> Plays Critical Role in Exacerbating Inflammaging in High Fat Diet Induced Skin
Yan Liang, Tianya Gu, Peng Su et al. · 2022 · Oxidative Medicine and Cellular Longevity · 11 citations
Background . Long term high fat diets (HFD) promote skin aging pathogenesis, but detailed mechanisms remain unclear especially for inflammaging, which has recently emerged as a pathway correlating ...
The Intersection of Dermatological Dilemmas and Endocrinological Complexities: Understanding Necrobiosis Lipoidica—A Comprehensive Review
Corina Mihaela Ionescu, Aida Petca, Mihai Cristian Dumitrașcu et al. · 2024 · Biomedicines · 7 citations
Background: Necrobiosis lipoidica (NL) is a rare granulomatous skin disorder with a predilection for females, often associated with diabetes mellitus (DM). This paper aims to comprehensively review...
Skin manifestations in rare types of diabetes and other endocrine conditions
Felix Reschke, Torben Biester, Thekla von dem Berge et al. · 2023 · Endocrine Connections · 3 citations
As the most visible and vulnerable organ of the human organism, the skin can provide an impression of its state of health. Rare forms of diabetes and endocrinopathies are often diagnosed late or pr...
Reading Guide
Foundational Papers
Duff et al. (2015) first for diabetes skin prevalence (79.2%, 129 citations), then Svoboda and Shields (2021) for obesity hyperinsulinemia mechanisms.
Recent Advances
Liang et al. (2022) on p16INK4a inflammaging; Naumowicz et al. (2024) and Ionescu et al. (2024) on necrobiosis lipoidica updates.
Core Methods
Hyperinsulinemia pathway analysis (Svoboda 2021); high-fat diet mouse models (Liang 2022); granulomatous histology (Naumowicz 2024).
How PapersFlow Helps You Research Obesity-Related Cutaneous Changes
Discover & Search
Research Agent uses searchPapers('obesity acanthosis nigricans striae') and citationGraph on Duff et al. (2015, 129 citations) to map 50+ related papers on diabetes-obesity skin links. exaSearch uncovers microbiome studies like Liang et al. (2022); findSimilarPapers expands to Svoboda and Shields (2021).
Analyze & Verify
Analysis Agent applies readPaperContent to extract hyperinsulinemia mechanisms from Svoboda and Shields (2021), then verifyResponse with CoVe against Duff et al. (2015). runPythonAnalysis processes citation data via pandas for prevalence stats (e.g., 79.2% skin disorders), with GRADE grading for evidence quality in inflammaging claims (Liang et al., 2022).
Synthesize & Write
Synthesis Agent detects gaps in biomechanical models via gap detection on 20 papers, flags contradictions in infection etiologies. Writing Agent uses latexEditText for dermatology reports, latexSyncCitations for Duff et al. (2015), and latexCompile for publication-ready reviews; exportMermaid diagrams skin barrier pathways.
Use Cases
"Analyze prevalence of acanthosis in obese diabetics from recent papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis(pandas on extracted stats from Duff et al. 2015, Svoboda 2021) → CSV export of 79.2% rates and trends.
"Write LaTeX review on obesity striae treatments"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations(Duff 2015) + latexCompile → PDF with intervention tables.
"Find code for skin microbiome analysis in obesity papers"
Research Agent → paperExtractUrls(Liang 2022) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for p16INK4a inflammaging models.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'obesity cutaneous changes diabetes', producing GRADE-graded systematic review with Duff et al. (2015) centrality. DeepScan applies 7-step CoVe to verify microbiome claims in Liang et al. (2022), checkpointing statistical analyses. Theorizer generates hypotheses on hyperinsulinemia-striae links from Svoboda and Shields (2021).
Frequently Asked Questions
What defines obesity-related cutaneous changes?
Skin alterations like acanthosis nigricans, striae, and infections from obesity's effects on barrier and immunity (Svoboda and Shields, 2021).
What are key methods studied?
Immunohistochemistry for spike protein in lesions (Santonja et al., 2020); p16INK4a analysis in high-fat diet skin (Liang et al., 2022).
What are seminal papers?
Duff et al. (2015, 129 citations) on diabetes skin manifestations; Svoboda and Shields (2021, 18 citations) on hyperglycemia effects.
What open problems exist?
Biomechanical models for striae; microbiome interventions; RCTs for obese diabetic skin treatments (Naumowicz et al., 2024).
Research Skin Diseases and Diabetes with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Obesity-Related Cutaneous Changes with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Skin Diseases and Diabetes Research Guide